BGC201531
CAS No. 1186532-61-5
BGC201531( GTPL3380 | AP-1531 | BGC-20-1531 )
Catalog No. M23357 CAS No. 1186532-61-5
BGC201531 is a EP4 antagonist for the treatment of acute migraine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 272 | In Stock |
|
10MG | 408 | In Stock |
|
25MG | 735 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBGC201531
-
NoteResearch use only, not for human use.
-
Brief DescriptionBGC201531 is a EP4 antagonist for the treatment of acute migraine.
-
DescriptionBGC201531 is a EP4 antagonist for the treatment of acute migraine.
-
In Vitro——
-
In Vivo——
-
SynonymsGTPL3380 | AP-1531 | BGC-20-1531
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorEP4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1186532-61-5
-
Formula Weight496.58
-
Molecular FormulaC26H28N2O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC=CC=C1S(=O)(=O)[N-]C(=O)C2=CC(=C(O2)C)COC3=CC=C(C=C3)C4=NC=C(C=C4)OC.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Czigler A , Toth L , Szarka N , et al. Prostaglandin E2, a postulated mediator of neurovascular coupling, at low concentrations dilates whereas at higher concentrations constricts human cerebral parenchymal arterioles[J]. Prostaglandins & other lipid mediators, 2019, 146:106389.
molnova catalog
related products
-
2-Acetylbenzoic acid
2-Acetylbenzoic acid is more potent than 2-propionyloxybenzoic acid in inhibiting platelet function and platelet prostaglandin (PG) synthesis although the potencies of these agents were comparable in inhibiting prostacyclin (PGI2) synthesis.
-
ONO-1301
A stable, orally active, non-prostanoid prostacyclin I2 (PGI2) mimetic and prostacyclin agonist with inhibitory activity against thromboxane A2 synthase.
-
EP4 receptor antagon...
EP4 receptor antagonist 1 inhibits human and mouse EP4 receptor with IC50s of 6.1 nM and 16.2 nM, respectively.